Adverse reactions caused by consecutive injections of different fillers in the same facial region: Risk assessment based on the results from the Injectable Filler Safety study

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 8, 2011, Pages 902-912

  Bachmann, F ^a   Erdmann, R ^a   Hartmann, V ^a   Becker Wegerich, P ^b   Wiest, L ^c   Rzany, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Aesthetik und Laserzentrum Zürichsee ^*  (Switzerland)

^c Über der Klause 1   (Germany)

Author keywords

combination; combined; complications; fillers; injectable; reactions

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; FILLER; POLYLACTIC ACID;

ABSCESS; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BIODEGRADABLE IMPLANT; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE REGISTRY; FACE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PRURITUS; RISK ASSESSMENT; SKIN DISCOLORATION; SKIN NODULE;

ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; DERMATOLOGIC AGENTS; DRUG INTERACTIONS; FACE; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MALE; METHYLMETHACRYLATES; MIDDLE AGED; POLYHYDROXYETHYL METHACRYLATE; POLYMERS; POLYMETHYL METHACRYLATE; REGISTRIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 79960233408     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03878.x     Document Type: Article

References (35)

1. GCD. Neue Statistik der Schönheitsoperationen Gesellschaft für sthetische Chirurgie Deutschland e.V. präsentiert Zahlen von 2008; Pressemitteilung der GCD [WWW document] 2008. URL (last accessed: 26 April 2010).
2. ASAPS 2007 Data. Injectable anti-aging treatments. [WWW document] 2007.URL (last accessed: 12 June 2009).
3. Broder KW, Cohen SR,. An overview of permanent and semipermanent fillers. Plast Reconstr Surg 2006; 118: 7S-14S. (Pubitemid 44319085)
4. Eppley BL, Dadvand B,. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg 2006; 118: 98e-106e. (Pubitemid 44412913)
5. Wiest LG,. [History and use of fillers for treating wrinkles]. Hautarzt 2007; 58: 224-231. (Pubitemid 46445994)
6. Zielke H, Wolber L, Wiest L, Rzany B,. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg 2008; 34: 326-335; discussion 335. (Pubitemid 351316823)
7. Beer K,. Dermal fillers and combinations of fillers for facial rejuvenation. Dermatol Clin 2009; 27: 427-432, v.
8. Nicolau PJ,. Long-lasting and permanent fillers: biomaterial influence over host tissue response. Plast Reconstr Surg 2007; 119: 2271-2286. (Pubitemid 46847128)
9. Pons-Guiraud A,. Actualisation des effets secondaires des produits de comblement des rides. Nouv Dermatol 2003; 22: 202-204.
10. Bachmann F, Erdmann R, Hartmann V, Wiest L, Rzany B,. The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg 2009; 35 (Suppl. 2): 1629-1634.
11. Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest LG, Rzany B,. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study. J Cosmet Dermatol 2009; 8: 14-18.
12. Rossner F, Rossner M, Kahl C, Rzany B,. Klinisches Spektrum unerwünschter Reaktionen auf injizierbare Füllmaterialien: Fallberichte aus dem Berliner Register. Kosmetische Medizin 2006; 27: 4-8.
13. Rossner M, Rossner F, Bachmann F, Wiest L, Rzany B,. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid. Dermatol Surg 2009; 35 (Suppl. 1): 367-374.
14. Narins RS, Dayan SH, Brandt FS, Baldwin EK,. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 2008; 34 (Suppl. 1); S2-S8; discussion S8. (Pubitemid 351792840)
15. El-Shafey I,. Complications from repeated injection or puncture of old polyarylamide gel implants sites: Case reports. Aesthetic Plast Surg 2007; 32: 162-165.
16. Alijotas-Reig J, Garcia-Gimenez V, Miro-Mur F, Vilardell-Tarres M,. Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up. Dermatol Surg 2009; 35 (Suppl. 1): 360-366.
17. Bentkover SH,. The biology of facial fillers. Facial Plast Surg 2009; 25: 73-85.
18. Christensen L,. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007; 33 (Suppl. 2): S168-S175. (Pubitemid 350233456)
19. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E,. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29: 34-48. (Pubitemid 40685159)
20. Christensen LH,. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 2009; 35 (Suppl. 2): 1612-1619.
21. Wiest LG, Stolz W, Schroeder JA,. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients. Dermatol Surg 2009; 35 (Suppl. 2): 1681-1688.
22. Laeschke K,. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg 2004; 23: 214-217. (Pubitemid 43180994)
23. Lemperle G, Morhenn VB, Pestonjamasp V, Gallo RL,. Migration studies and histology of injectable microspheres of different sizes in mice. Plast Reconstr Surg 2004; 113: 1380-1390. (Pubitemid 39201868)
24. Gelb H, Schumacher HR, Cuckler J, Ducheyne P, Baker DG,. In vivo inflammatory response to polymethylmethacrylate particulate debris: effect of size, morphology, and surface area. J Orthop Res 1994; 12: 83-92. (Pubitemid 24070792)
25. Tomazic-Jezic VJ, Merritt K, Umbreit TH,. Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution. J Biomed Mater Res 2001; 55: 523-529. (Pubitemid 32336282)
26. Sanger JR, Kolachalam R, Komorowski RA, Yousif NJ, Matloub HS,. Short-term effect of silicone gel on peripheral nerves: a histologic study. Plast Reconstr Surg 1992; 89: 931-940; discussion 941-932.
27. Okada Y, Kobayashi M, Fujita H, et al. Transmission electron microscopic study of interface between bioactive bone cement and bone: comparison of apatite and wollastonite containing glass-ceramic filler with hydroxyapatite and beta-tricalcium phosphate fillers. J Biomed Mater Res 1999; 45: 277-284. (Pubitemid 29196673)
28. Rizzi SC, Heath DJ, Coombes AG, Bock N, Textor M, Downes S,. Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. J Biomed Mater Res 2001; 55: 475-486. (Pubitemid 32336277)
29. Freitas RA Jr., Alumina and sapphire particles. [WWW document] 2003. NanomedicineBookSite. URL (last accessed: 13 December 2008).
30. Eppley BL, Summerlin DJ, Prevel CD, Sadove AM,. Effects of a positively charged biomaterial for dermal and subcutaneous augmentation. Aesthetic Plast Surg 1994; 18: 413-416. (Pubitemid 24307276)
31. Mustoe TA, Weber DA, Krukowski M,. Enhanced healing of cutaneous wounds in rats using beads with positively charged surfaces. Plast Reconstr Surg 1992; 89: 891-897; discussion 898-899.
32. Eppley BL, Sadove AM, Holmstrom H, Kahnberg KE,. HTR polymer facial implants: a five-year clinical experience. Aesthetic Plast Surg 1995; 19: 445-450.
33. Nagura H, Asai J, Kojima K,. Studies on the mechanism of phagocytosis. I. Effect of electric surface charge on phagocytic activity of macrophages for fixed red cells. Cell Stuct Funct 1977; 2: 21.
34. Tabata Y, Ikada Y,. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988; 9: 356-362.
35. de Maio M, Rzany B,. Injectable Fillers in Aesthetic Medicine. Springer, Berlin, 2006; ISBN 3540239413.